JP2011509942A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509942A5
JP2011509942A5 JP2010542415A JP2010542415A JP2011509942A5 JP 2011509942 A5 JP2011509942 A5 JP 2011509942A5 JP 2010542415 A JP2010542415 A JP 2010542415A JP 2010542415 A JP2010542415 A JP 2010542415A JP 2011509942 A5 JP2011509942 A5 JP 2011509942A5
Authority
JP
Japan
Prior art keywords
carbon atoms
compound
alkyl
hydrogen
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010542415A
Other languages
English (en)
Japanese (ja)
Other versions
JP5496913B2 (ja
JP2011509942A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/030845 external-priority patent/WO2009091732A1/en
Publication of JP2011509942A publication Critical patent/JP2011509942A/ja
Publication of JP2011509942A5 publication Critical patent/JP2011509942A5/ja
Application granted granted Critical
Publication of JP5496913B2 publication Critical patent/JP5496913B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010542415A 2008-01-15 2009-01-13 代謝異常の治療のための化合物 Expired - Fee Related JP5496913B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2106108P 2008-01-15 2008-01-15
US61/021,061 2008-01-15
US9657608P 2008-09-12 2008-09-12
US61/096,576 2008-09-12
PCT/US2009/030845 WO2009091732A1 (en) 2008-01-15 2009-01-13 Compounds for the treatment of metabolic disorders

Publications (3)

Publication Number Publication Date
JP2011509942A JP2011509942A (ja) 2011-03-31
JP2011509942A5 true JP2011509942A5 (enExample) 2012-02-16
JP5496913B2 JP5496913B2 (ja) 2014-05-21

Family

ID=40885627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010542415A Expired - Fee Related JP5496913B2 (ja) 2008-01-15 2009-01-13 代謝異常の治療のための化合物

Country Status (4)

Country Link
US (1) US8481595B2 (enExample)
EP (1) EP2240024A4 (enExample)
JP (1) JP5496913B2 (enExample)
WO (1) WO2009091732A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090176885A1 (en) * 2006-02-02 2009-07-09 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
MX2010009959A (es) 2008-03-13 2010-10-04 Wellstat Therapeutics Corp Compuestos y metodo para reducir el acido urico.

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE949521C (de) * 1955-01-09 1956-09-20 Merck Ag E Lichtschutzmittel
US3772389A (en) * 1971-06-24 1973-11-13 Eastman Kodak Co Process for the synthesis of phenyl esters
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
JP2854406B2 (ja) 1990-09-28 1999-02-03 昭和電工株式会社 βーケトカルボン酸誘導体
JPH0848664A (ja) * 1994-08-05 1996-02-20 Hisamitsu Pharmaceut Co Inc 新規なグアニジノ安息香酸エステル誘導体
US6541521B1 (en) * 1999-07-12 2003-04-01 Warner-Lambert Company Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases
WO2001036351A2 (en) * 1999-11-19 2001-05-25 Corvas International, Inc. Plasminogen activator inhibitor antagonists related applications
US6791453B1 (en) * 2000-08-11 2004-09-14 Walter Kidde Portable Equipment, Inc. Communication protocol for interconnected hazardous condition detectors, and system employing same
HUP0400280A3 (en) * 2001-06-07 2006-01-30 Ligand Pharmaceuticals Inc San Modulators of peroxisome proliferator activated receptors, process for their preparation and pharmaceutical compositions containing them
KR100965201B1 (ko) * 2001-06-12 2010-06-24 웰스테트 테라퓨틱스 코포레이션 대사 질환의 치료용 화합물
JP4139151B2 (ja) 2002-07-08 2008-08-27 大日本印刷株式会社 有機エレクトロルミネッセント画像表示装置
US20050009055A1 (en) * 2002-07-12 2005-01-13 Affymetrix, Inc. System and method for examination of microarrays using scanning electron microscope
US7645772B2 (en) * 2002-11-01 2010-01-12 Wellstat Therapeutics Corporation Treatment of metabolic disorders
EP1601251B1 (en) * 2003-02-13 2014-11-12 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
DK1633340T3 (da) * 2003-04-15 2011-02-07 Wellstat Therapeutics Corp Forbindelser til behandling af stofskifteforstyrrelser
CN1777576A (zh) * 2003-04-22 2006-05-24 维尔斯达医疗公司 用于治疗代谢紊乱的化合物
US7442796B2 (en) * 2003-04-30 2008-10-28 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
CA2533890A1 (en) * 2003-08-20 2005-03-03 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
UA95613C2 (ru) * 2005-11-09 2011-08-25 Уеллстат Терепьютикс Корпорейшн Соединения для лечения расстройсв метаболизма
WO2007087505A2 (en) * 2006-01-25 2007-08-02 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
JP2009524686A (ja) * 2006-01-25 2009-07-02 ウェルスタット セラピューティクス コーポレイション 代謝障害を処置するための化合物
AU2007208127A1 (en) * 2006-01-25 2007-08-02 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US8044243B2 (en) * 2006-02-13 2011-10-25 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
MX2008011022A (es) * 2006-02-28 2008-09-10 Wellstat Therapeutics Corp Compuestos para el tratamiento de trastornos metabolicos.
WO2007117791A2 (en) * 2006-03-31 2007-10-18 Wellstat Therapeutics Corporation Combination treatment of metabolic disorders
JP2009537559A (ja) * 2006-05-18 2009-10-29 ウェルスタット セラピューティクス コーポレイション 代謝障害の処置のための化合物
EP2026659A4 (en) * 2006-06-09 2010-06-30 Wellstat Therapeutics Corp COMPOUNDS FOR THE TREATMENT OF METABOLISM DISORDER
AU2007285827A1 (en) * 2006-08-17 2008-02-21 Wellstat Therapeutics Corporation Combination treatment for metabolic disorders

Similar Documents

Publication Publication Date Title
JP2009537559A5 (enExample)
JP2009531280A5 (enExample)
JP2009528375A5 (enExample)
US10300060B2 (en) Trk-inhibiting compound
RU2005128501A (ru) Соединение для лечения метаболических расстройств
JP2009530398A5 (enExample)
JP2006524252A5 (enExample)
JP2007523155A5 (enExample)
JP2006143751A5 (enExample)
JP2016539144A5 (enExample)
JP2008513499A5 (enExample)
JP2009533410A5 (enExample)
JP2008513514A5 (enExample)
JP2016505551A5 (enExample)
JP2012533546A5 (enExample)
CA2521621A1 (en) Compounds for the treatment of metabolic disorders
RU2008123000A (ru) Соединения для лечения метаболических нарушений
CA2522738A1 (en) Compounds for the treatment of metabolic disorders
JP2010516701A5 (enExample)
CA2521589A1 (en) Compounds for the treatment of metabolic disorders
JP2017503760A5 (enExample)
JP2011517697A5 (enExample)
JP2010540666A5 (enExample)
JP2005529965A5 (enExample)
JP2009528997A5 (enExample)